MOSAIC: A Qualitative Study of the Clinical, Humanistic, and Financial Burden of Geographic Atrophy (GA) Among Patients and Caregivers

Access Resources

Detailed Baseline Demographics and Disease Characteristics of Patients with Geographic Atrophy Enrolled in the Phase 3 OAKS and DERBY Clinical Trials…and Why it Matters!

Access Resources

Assessment of Geographic Atrophy Lesion Progression in the Phase 3 DERBY and OAKS Trials

Access Resources

Retrospective Real-World Analysis of Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration Followed up for 3 Years

Access Resources

Characterizing Real-World Functional Outcomes in Patients With Geographic Atrophy: An IRIS Registry Analysis

Access Resources

Relationship Between Number of Intermediate/Large Drusen and Geographic Atrophy Lesion Growth Rate in the Sham Groups of the DERBY, OAKS, and FILLY Trials

Access Resources